Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises on the sale of Memira
Mandate

Vinge advises on the sale of Memira

July 08, 2019 M&A

Vinge has advised Patricia Industries AB, part of Investor AB, and other shareholders in Memira Holding AB in connection with the sale of the company to the Dutch company Bergman Clinics BV.

With 47 clinics, Memira is the Nordic Region’s leading chain providing sight correction operations and one of the leading actors in the world in relation to change of lenses.

The transaction is subject to customary closing conditions.

Vinge’s team primarily consisted of Johan Winnerblad, Kristina Ekberg, Karl Klackenberg, Martin Cronsioe, Milad Kamali, Daniel Wendelsson, Maria Schultzberg, Henrik Wastensson and Sofie Sundin. 

Related

Vinge advises Egetis Therapeutics in connection with ANI Pharmaceuticals’ public cash offer

 On 5 November 2026, ANI Pharmaceuticals, Inc., a U.S. biopharmaceutical company listed on The Nasdaq Global Market, announced a recommended public cash offer to the shareholders of Egetis Therapeutics AB (publ) and to the holder of Egetis’ convertible loan and warrants to tender all shares, the convertible loan and the warrants in Egetis to ANI. The total value of the offer amounts to approximately SEK 5,304 million.
November 10, 2026

Vinge has advised Xspray Pharma in connection with its rights issue

 Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 90 million before transaction costs, with an over-allotment issue of approximately SEK 72 million.
November 09, 2026

Vinge advises SenzaGen on its acquisition of Alcyomics

 SenzaGen AB (publ) has acquired Alcyomics Ltd. The transaction is being financed through a combination of existing cash and a directed issue of convertible bonds.
November 09, 2026